Abstract
Calcium-sensing receptor (CaSR) is widely involved in the cell proliferation, differentiation, migration, adhesion and apoptosis, which can affect the vascular remodeling in the humanbody. The main ligand of CaSR is extracellular Ca2+. CaSR has the physiological significance in Ca2+ homeostasis. Pulmonary vascular remodeling is one of the main histopathological changes of pulmonary hypertension (PH). The abnormal proliferation of pulmonary artery smooth muscle cells (PASMCs) results in the pulmonary vascular remodeling. CaSR is an important regulator of [Ca2+]i. [Ca2+]i is the main cause of the excessive pulmonary vascular remodeling in patients with PH. In this review, it was conclued that the structure of CaSR was prone to explore the devolopment or the treatment of PH. It was found that the regulation of CaSR with some miRNA could inhibit the proliferation of PASMCs, and that CaSR could affect the occurrence of autophagy in PH. Therefore, CaSR would become a new therapeutic target to PH.
Similar content being viewed by others
References
Brennan SC, Wilkinson WJ, Tseng HE et al (2016) The extracellular calcium-sensing receptor regulates human fetal lung development via CFTR. Sci Rep 6:21975
Guo Q, Huang JA, Yamamura A et al (2014) Inhibition of the Ca(2+)-sensing receptor rescues pulmonary hypertension in rats and mice. Hypertens Res 37(2):116–124
Handoko ML, de Man FS, Allaart CP et al (2010) Perspectives on novel therapeutic strategies for right heart failure in pulmonary arterial hypertension: lessons from the left heart. Eur Respir Rev 19(115):72–82
Hoeper MM, Bogaard HJ, Condliffe R et al (2014) Pulmoner hipertansiyon tanı ve tanımlar [Definitions and diagnosis of pulmonary hypertension]. Turk Kardiyol Dern Ars 42(Suppl 1):55–66
Hassoun PM, Mouthon L, Barberà JA et al (2009) Inflammation, growth factors, and pulmonary vascular remodeling. J Am Coll Cardiol 54(1 Suppl):S10–S19
Yamamura A, Guo Q, Yamamura H et al (2012) Enhanced Ca(2+)-sensing receptor function in idiopathic pulmonary arterial hypertension. Circ Res 111(4):469–481
Li MX, Jiang DQ, Wang Y et al (2016) Signal mechanisms of vascular remodeling in the development of pulmonary arterial hypertension. J Cardiovasc Pharmacol 67(2):182–190
Hendy GN, Canaff L, Cole DE (2013) The CASR gene: alternative splicing and transcriptional control, and calcium-sensing receptor (CaSR) protein: structure and ligand binding sites. Best Pract Res Clin Endocrinol Metab 27(3):285–301
Chavez-Abiega S, Mos I, Centeno PP et al (2020) Sensing extracellular calcium - an insight into the structure and function of the calcium-sensing receptor (CaSR). Adv Exp Med Biol 1131:1031–1063
Leach K, Hannan FM, Josephs TM et al (2020) International Union of Basic and Clinical Pharmacology. CVIII. Calcium-sensing receptor nomenclature, pharmacology, and function. Pharmacol Rev 72(3):558–604
Conigrave AD, Ward DT (2013) Calcium-sensing receptor (CaSR): pharmacological properties and signaling pathways. Best Pract Res Clin Endocrinol Metab 27(3):315–331
Vahe C, Benomar K, Espiard S et al (2017) Diseases associated with calcium-sensing receptor. Orphanet J Rare Dis 12(1):19
Brennan SC, Thiem U, Roth S et al (2013) Calcium sensing receptor signalling in physiology and cancer. Biochim Biophys Acta 1833(7):1732–1744
Tang H, Yamamura A, Yamamura H et al (2016) Pathogenic role of calcium-sensing receptors in the development and progression of pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 310(9):L846–L859
Guo Y, Yang X, He J et al (2018) Important roles of the Ca2+-sensing receptor in vascular health and disease. Life Sci 209:217–227
Schreckenberg R, Schlüter KD (2018) Calcium sensing receptor expression and signalling in cardiovascular physiology and disease [published online ahead of print, 2018 Mar 4]. Vascul Pharmacol S1537-1891(17):30323–30323
Li GW, Wang QS, Hao JH et al (2011) The functional expression of extracellular calcium-sensing receptor in rat pulmonary artery smooth muscle cells. J Biomed Sci 18(1):16
Smith KA, Ayon RJ, Tang H et al (2016) Calcium-sensing receptor regulates cytosolic [Ca2+] and plays a major role in the development of pulmonary hypertension. Front Physiol 7:517
Zhang J, Zhou J, Cai L et al (2012) Extracellular calcium-sensing receptor is critical in hypoxic pulmonary vasoconstriction. Antioxid Redox Signal 17(3):471–484
Peng X, Li HX, Shao HJ et al (2014) Involvement of calcium-sensing receptors in hypoxia-induced vascular remodeling and pulmonary hypertension by promoting phenotypic modulation of small pulmonary arteries. Mol Cell Biochem 396(1–2):87–98
Zhu L, Xiao R, Zhang X et al (2019) Spermine on endothelial extracellular vesicles mediates smoking-induced pulmonary hypertension partially through calcium-sensing receptor. Arterioscler Thromb Vasc Biol 39(3):482–495
Penumatsa KC, Toksoz D, Warburton RR et al (2014) Role of hypoxia-induced transglutaminase 2 in pulmonary artery smooth muscle cell proliferation. Am J Physiol Lung Cell Mol Physiol 307(7):L576–L585
Nakamura H, Zimmer J, Lim T et al (2018) Increased CaSR and TRPC6 pulmonary vascular expression in the nitrofen-induced model of congenital diaphragmatic hernia. Pediatr Surg Int 34(2):211–215
Hoeper MM, Ghofrani HA, Grünig E et al (2017) Pulmonary hypertension. Dtsch Arztebl Int 114(5):73–84
Yamamura A, Nayeem MJ, Al Mamun A et al (2019) Platelet-derived growth factor up-regulates Ca2+-sensing receptors in idiopathic pulmonary arterial hypertension. FASEB J 33(6):7363–7374
AgarLi C, Qin F, Xue M et al (2019) miR-429 and miR-424-5p inhibit cell proliferation and Ca2+ influx by downregulating CaSR in pulmonary artery smooth muscle cells. Am J Physiol Cell Physiol 316(1):C111–C120
Agarwal V, Bell GW, Nam JW et al (2015) Predicting effective microRNA target sites in mammalian mRNAs. Elife 4:e05005 Published 2015 Aug 12
Luo L, Hong X, Diao B et al (2018) Sulfur dioxide attenuates hypoxia-induced pulmonary arteriolar remodeling via Dkk1/Wnt signaling pathway. Biomed Pharmacother 106:692–698
Morris HE, Neves KB, Montezano AC et al (2019) Notch3 signalling and vascular remodelling in pulmonary arterial hypertension. Clin Sci (Lond) 133(24):2481–2498
Guo Q, Xu H, Yang X et al (2017) Notch activation of Ca2+-sensing receptor mediates hypoxia-induced pulmonary hypertension. Hypertens Res 40(2):117–129
Zeng X, Zhu L, Xiao R et al (2017) Hypoxia-induced mitogenic factor acts as a nonclassical ligand of calcium-sensing receptor, therapeutically exploitable for intermittent hypoxia-induced pulmonary hypertension. Hypertension 69(5):844–854
Li J, Jia M, Liu M et al (2020) The effect of activated κ-opioid receptor (κ-OR) on the role of calcium sensing receptor (CaSR) in preventing hypoxic pulmonary hypertension development. Biomed Pharmacother 125:109931
Montani D, Günther S, Dorfmüller P et al (2013) Pulmonary arterial hypertension. Orphanet J Rare Dis 8:97 Published 2013 Jul 6
Foshat M, Boroumand N (2017) The evolving classification of pulmonary hypertension. Arch Pathol Lab Med 141(5):696–703
Lambert M, Capuano V, Olschewski A et al (2018 Oct 14) Ion channels in pulmonary hypertension: a therapeutic interest? Int J Mol Sci 19(10):3162
Puri A, McGoon MD, Kushwaha SS (2007) Pulmonary arterial hypertension: current therapeutic strategies. Nat Clin Pract Cardiovasc Med 4(6):319–329
Yamamura A (2016) Molecular mechanism of dihydropyridine Ca2+ channel blockers in pulmonary hypertension. Yakugaku Zasshi 136(10):1373–1377
Yamamura A, Yamamura H, Guo Q et al (2013) Dihydropyridine Ca(2+) channel blockers increase cytosolic [Ca(2+)] by activating Ca(2+)-sensing receptors in pulmonary arterial smooth muscle cells. Circ Res 112(4):640–650
Xiao R, Su Y, Feng T et al (2017) Monocrotaline Induces Endothelial Injury and Pulmonary Hypertension by Targeting the Extracellular Calcium-Sensing Receptor. J Am Heart Assoc 6(4):e004865 Published 2017 Mar 22
Yamamura A, Yagi S, Ohara N et al (2016) Calcilytics enhance sildenafil-induced antiproliferation in idiopathic pulmonary arterial hypertension. Eur J Pharmacol 784:15–21
Mizushima N, Komatsu M (2011) Autophagy: renovation of cells and tissues. Cell 147(4):728–741
Goncharova EA (2013) mTOR and vascular remodeling in lung diseases: current challenges and therapeutic prospects. FASEB J 27(5):1796–1807
Klionsky DJ, Abdelmohsen K, Abe A et al (2016) Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) [Published correction appears in autophagy]. Autophagy 12(1):1–222
Lee SJ, Smith A, Guo L et al (2011) Autophagic protein LC3B confers resistance against hypoxia-induced pulmonary hypertension. Am J Respir Crit Care Med 183(5):649–658
Chen R, Jiang M, Li B et al (2018) The role of autophagy in pulmonary hypertension: a double-edge sword. Apoptosis 23(9–10):459–469
Long L, Yang X, Southwood M et al (2013) Chloroquine prevents progression of experimental pulmonary hypertension via inhibition of autophagy and lysosomal bone morphogenetic protein type II receptor degradation. Circ Res 112(8):1159–1170
Peng X, Wei C, Li HZ et al (2019) NPS2390, a Selective Calcium-sensing Receptor Antagonist Controls the Phenotypic Modulation of Hypoxic Human Pulmonary Arterial Smooth Muscle Cells by Regulating Autophagy. J Transl Int Med 7(2):59–68 Published 2019 Jul 11
Liu L, Wang C, Lin Y et al (2016) Suppression of calcium-sensing receptor ameliorates cardiac hypertrophy through inhibition of autophagy. Mol Med Rep 14(1):111–120
Mattar P, Bravo-Sagua R, Tobar N et al (2018) Autophagy mediates calcium-sensing receptor-induced TNFα production in human preadipocytes. Biochim Biophys Acta Mol basis Dis 1864(11):3585–3594
Vonk Noordegraaf A, Groeneveldt JA, Bogaard HJ (2016 Mar) Pulmonary hypertension. Eur Respir Rev 25(139):4–11
Funding
This research was funded by National Natural Science Foundation of China (No. 81973404, 81503058), Department of Education of Liaoning Province (No. JC2019034), Natural Science Foundation of Liaoning Province (No. 2014021065).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there are no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zhou, MY., Cheng, L., Chen, L. et al. Calcium-sensing receptor in the development and treatment of pulmonary hypertension. Mol Biol Rep 48, 975–981 (2021). https://doi.org/10.1007/s11033-020-06065-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-020-06065-3